Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proton vs Photon Therapy Plus Carbon Ion Boost for Nasopharyngeal Carcinoma
NCT06846450Phase 3Recruiting
- Start
- Apr 2025
- Primary completion
- Jan 2031
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in nasopharyngeal carcinoma (NPC) (2 arms). Primary endpoint: Progression-free survival at 3 years. Started Apr 2025; status: recruiting.
02
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT06846450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06846450.